To evaluate the Safety and efficacy of Unani formulations in Productive Cough

Phase 2

Recruiting

• Conditions: Cough, SuÄl Ratab (Productive Cough).,

• Registration Number: CTRI/2013/11/004171
• Lead Sponsor: Central Council for Research in Unani Medicine CCRUM New Delhi

Brief Summary

This study is designed as a multicentric open trial in patients with *SuÄl Ratab* (Productive Cough).After screening, Patients will be enrolled if they satisfy the inclusion and exclusion criteria. The patients will be assessed clinically on follow up. This includes subjective assessment of general well being and physical examination. The total duration of treatment will be 2 weeks . Laboratory parameters for safety assessment will be conducted at baseline and end of study

Composition of SharbatZufa Murakkab:

-Injeer (Ficus carica Linn.)                          10 pcs.

2-Tukhm Khatmi (Althaea officinalis Linn.) 10.5 g

3-Aslus Soos  (Glycyrrhiza glabraLinn.)      10.5 g

4-Irsa  (Iris ensata Thunb.)                             10.5 g

5-Zufa Khushk  (H. officinalis Linn.)          24 g

6- Maweez Munaqqa (V. vinifera Linn.)       108 g

Detailed Description

Not available

Study Timeline

• Study Start: 2013-03-13
• Last Update Posted: 2018-03-12

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 540

Inclusion Criteria

• Patients of either sex in the age group of 18-65 2.
• Associated with expectoration.

Exclusion Criteria

• Cases of non-productive cough 2.
• Known cases of respiratory diseases needed concomitant therapy e.g. Pneumonia, Bronchiectasis, Bronchial Asthma, Pulmonary Tuberculosis and Lung Carcinoma.
• Known cases of Renal/ Hepatic/ Cardiac impairment or the ailments needing long term therapy 4.
• Pregnant or lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in signs and symptoms of SuÄl Ratab (Productive Cough).	2WEEKS

Secondary Outcome Measures

Name	Time	Method
Haematological and biochemical assessment for safety assessment	2 WEEKS

Trial Locations

Locations (7)

CLINICAL RESEARCH UNIT (CRU), KARIMGANJ; 🇮🇳 Karimganj, ASSAM, India

CLINICAL RESEARCH UNIT (CRU), KURNOOL; 🇮🇳 Kurnool, ANDHRA PRADESH, India

REGIONAL RESEARCH CENTRE (RRC), SILCHAR; 🇮🇳 Cachar, ASSAM, India

REGIONAL RESEARCH INSTITUTE OF UNANI MEDICINE, BHADRAK; 🇮🇳 Bhadrak, ORISSA, India

REGIONAL RESEARCH INSTITUTE OF UNANI MEDICINE, CHENNAI; 🇮🇳 Chennai, TAMIL NADU, India

REGIONAL RESEARCH INSTITUTE OF UNANI MEDICINE, MUMBAI; 🇮🇳 Mumbai, MAHARASHTRA, India

REGIONAL RESEARCH INSTITUTE OF UNANI MEDICINE, PATNA; 🇮🇳 Patna, BIHAR, India

CLINICAL RESEARCH UNIT (CRU), KARIMGANJ

🇮🇳Karimganj, ASSAM, India

DR WAHIDUZZAMAN

Principal investigator

03843267522

cru_kxj@rediffmail.com